Given that DKC1 can drive CRC proliferation by activating the RAS/RAF/MEK/ERK signaling pathway [10], which integrates surface receptor signals into nuclear pathways, we hypothesize that TRUB1 may similarly influence CRC development and prognosis through nuclear pathways. This evidence concerns the gene MAP2K7 and colorectal carcinoma.